Photo by Ali Marwan on Pexels
Sklerosis Difus (G37.0): Penyebab, Gejala, Diagnosis, dan Tatalaksana
📚 Daftar Pustaka (APA 7)
[1]
Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a multisystemic disorder. Neurology. 2005;65(5):739-748.
[2]
Gieselmann V, Krägeloh-Mann I. Metachromatic leukodystrophy – an update. Neuropediatrics. 2010;41(1):1-6.
[3]
Wenger DA, Rafi MA, Luzi P. Krabbe disease: one hundred years from the bedside to the bench to the bedside. J Neurosci Res. 2016;94(11):982-989.
[4]
Loes DJ, Hite S, Moser H, et al. Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol. 1994;15(9):1761-1766.
[5]
Barkhof F, Scheltens P, Frequin ST, et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. Radiology. 1992;183(2):461-470.
[6]
Moser AB, Kreiter N, Bezman L, et al. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann Neurol. 1999;45(1):100-110.
[7]
Köhler W, Curiel J. Adulthood leukodystrophies. Nat Rev Neurol. 2018;14(2):94-105.
[8]
van Rappard DF, Boelens JJ, Wolf NI. Metachromatic leukodystrophy: disease spectrum and approaches for treatment. Best Pract Res Clin Endocrinol Metab. 2015;29(2):261-273.
[9]
Patel H, Gultekin SH, Wenger DA. Clinicopathological correlates of adult-onset Krabbe disease. J Neurol Sci. 2019;397:95-101.
[10]
Eichler F, Van Haren K. Immune response in leukodystrophies. Pediatr Neurol. 2007;37(4):235-244.